BMS-025 is an orthogonal STING agonist that can induce chemical shifts in the STINGM271 residue, thereby further activating STINGIFN signal transduction. BMS-025 is applicable in the study of monogenic autoinflammatory diseases such as SAVI.
Target:
STING
* VAT and and shipping costs not included. Errors and price changes excepted
